King Pharmaceuticals - Crunchbase Company Profile & Funding

Overview

King Pharmaceuticals

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About King Pharmaceuticals

CB Rank

1711619

King Pharmaceuticals develops, manufactures and markets therapies and technologies in neuroscience, hospital and acute care medicines.

Acquired by

Pfizer

Founded

obfuscation

Delisted

Bristol, Tennessee, United States

10001+

www.kingpharm.com

Biotechnology

Health Care

Key People

James Elrod: Chief Legal Officer
Joseph Squicciarino: CFO

Details

Legal Name

King Pharmaceuticals, Inc.

Operating Status

Closed

Stock Symbol

NASDAQ:KING

Company Type

For Profit

Founders

John M. Gregory

About the Company

King Pharmaceuticals, Inc. (King) is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal health products. King's branded prescription pharmaceuticals include neuroscience products (primarily pain medicines), hospital

products and legacy brands, all of which are for use in humans. Its auto-injector business manufactures acute care medicines for use in humans that are delivered using an auto-injector. Its animal health business is focused on medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle and swine. King's business consists of four segments: a specialty-driven branded prescription pharmaceuticals business, global animal health business, Meridian auto-injector business, and royalties and other.